Neelima Denduluri, MD of Virginia Cancer Specialists gives an overview of the phase III study, the APHINITY trial, and its impact on future clinical practice and the treatment of adjuvant breast cancer. This was recorded at the 2017 Annual Meeting Annual Meeting in Chicago, IL.
Impact of APHINITY study on treatment of adjuvant breast cancer
